|
SLC35D1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.310600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.316200E-01 |
| Normal-vs-Stage2 |
7.945800E-01 |
| Normal-vs-Stage3 |
5.378400E-01 |
| Normal-vs-Stage4 |
1.948450E-01 |
| Stage1-vs-Stage2 |
7.262200E-01 |
| Stage1-vs-Stage3 |
6.493600E-01 |
| Stage1-vs-Stage4 |
2.694600E-01 |
| Stage2-vs-Stage3 |
5.673000E-01 |
| Stage2-vs-Stage4 |
3.328200E-01 |
| Stage3-vs-Stage4 |
5.472400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.785600E-01 |
| Normal-vs-AfricanAmerican |
7.785600E-04 |
| Normal-vs-Asian |
1.366370E-01 |
| Caucasian-vs-AfricanAmerican |
1.056990E-03 |
| Caucasian-vs-Asian |
4.866300E-02 |
| AfricanAmerican-vs-Asian |
3.801600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.025000E-01 |
| Normal-vs-Female |
7.823200E-01 |
| Male-vs-Female |
2.515000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.496000E-02 |
| Normal-vs-Age(41-60Yrs) |
7.016400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.184800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.228800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.266610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.168570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.484030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.777400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.116000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.152400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.556400E-01 |
| Normal-vs-Grade 2 |
6.823800E-01 |
| Normal-vs-Grade 3 |
7.479400E-01 |
| Normal-vs-Grade 4 |
3.009900E-02 |
| Grade 1-vs-Grade 2 |
3.011400E-01 |
| Grade 1-vs-Grade 3 |
4.315600E-01 |
| Grade 1-vs-Grade 4 |
9.892200E-01 |
| Grade 2-vs-Grade 3 |
5.144000E-01 |
| Grade 2-vs-Grade 4 |
2.997600E-02 |
| Grade 3-vs-Grade 4 |
1.014000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.042500E-02 |
| Normal-vs-ccB subtype |
1.177640E-01 |
| ccA subtype-vs-ccB subtype |
1.223890E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.092800E-01 |
| Normal-vs-N1 |
7.528000E-01 |
| N0-vs-N1 |
6.626800E-01 |
|
|
